How New Yorkers Get Money Back From Pfizer In Deceptively Advertised Drugs Case

Rockland/Westchester Journal News, The Journal News
Fri, 10/12/2018 - 7:01am

Pfizer is paying back $200,000 to consumers in a settlement with the Attorney General involving accusations of deceptively advertised drug prices

Sections: u.s.

13 Players to Watch in Section 4 Class D football in 2023
NYS Co-Player of the Year Caden Bellis of Tioga leads Players to Watch in Section 4 Class D football in 2023. More
17 Players to Watch in Section 4 Class C football in 2023
Five returning all-state picks from Waverly among talented crop of Players to Watch in Class C of Section 4 football. More
18 Players to Watch in Section 4 Class B football in 2023
A pair of returning first-team all-state football picks from state power Maine-Endwell are among Section 4 Class B Players to Watch. More
10 Players to Watch in Section 4 Class A football in 2023
All-state defensive lineman Qymani Viera-Powell of U-E among Class A Players to Watch in Section 4 football in 2023. More
Key players, expectations for Whitney Point football in 2023
Whitney Point hopes to turn the corner with winning record in second straight season in Section 4 independent division. More

BING NEWS:

Pfizer Options Trading: A Deep Dive into Market Sentiment
Having examined the options trading patterns of Pfizer, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance Trading volume ...
04/22/2024 - 4:30 am | View Link
Unveiling Pfizer's Potent Cocktail: Key Drivers Of Free Cash Flow Growth
Pfizer announced positive results from a pivotal clinical trial evaluating Abrysvo's efficacy against respiratory syncytial virus. See why PFE stock is a Buy.
04/19/2024 - 12:03 am | View Link
Trump’s jury starts to take shape: Seven New Yorkers now seated in historic hush money trial
Sitting with his attorneys in a criminal courtroom on Tuesday, Mr Trump craned his neck to get a good look at the group during the second day of jury selection in his landmark hush money case.
04/15/2024 - 1:00 pm | View Link
Is Pfizer Stock a Buy?
Pfizer ( PFE -1.82%) isn't exactly a hot stock right now. Since its massive run-up during the pandemic's height, built on hopes for its coronavirus vaccine, new sources of growth haven't led to ...
04/15/2024 - 1:45 am | View Link
Will Pfizer's (PFE) New Drugs Provide a Boost to 2024 Sales?
Pfizer’s CGRP receptor antagonist, Zavzpret/zavegepant nasal spray, for the acute treatment of migraine was approved in 2022. Among the newer drugs, all eyes are on Abrysvo RSV vaccine. Sales of ...
04/11/2024 - 2:12 am | View Link
More

MoviesWithButter : Our Sister Site